First Eagle Investment Management, LLC - KALOBIOS PHARMACEUTICALS INC ownership

KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 48 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
First Eagle Investment Management, LLC ownership history of KALOBIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$3,022,000
+11.6%
1,746,5910.0%0.01%0.0%
Q3 2014$2,707,000
-32.0%
1,746,5910.0%0.01%
-30.0%
Q2 2014$3,982,000
-15.9%
1,746,5910.0%0.01%
-23.1%
Q1 2014$4,733,000
+22.4%
1,746,591
+99.6%
0.01%
+18.2%
Q4 2013$3,868,000
-2.2%
875,0000.0%0.01%0.0%
Q3 2013$3,955,000875,0000.01%
Other shareholders
KALOBIOS PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 910,699$2,076,0000.92%
Opaleye Management Inc. 320,000$730,0000.63%
BVF INC/IL 1,162,000$2,649,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,786,783$6,354,0000.26%
SPHERA FUNDS MANAGEMENT LTD. 360,000$821,0000.20%
WALL STREET ASSOCIATES 608,300$1,387,0000.12%
Old West Investment Management, LLC 58,838$134,0000.08%
SSI INVESTMENT MANAGEMENT LLC 173,360$394,0000.04%
PRIMECAP MANAGEMENT CO/CA/ 4,475,700$10,205,0000.01%
First Eagle Investment Management, LLC 1,746,591$3,982,0000.01%
View complete list of KALOBIOS PHARMACEUTICALS INC shareholders